Instem

Instem is a leading provider of information technology applications tailored for the life sciences and healthcare sectors globally. The company focuses on enhancing drug and chemical development processes through software solutions that facilitate data collection, management, and analysis. Its diverse offerings include platforms for early phase clinical trials, toxicology resource planning, and various data acquisition and reporting tools. Notable products include ALPHADAS, Ames Study Manager, and Provantis, which serve different aspects of research and development. Additionally, Instem provides services related to regulatory information management, cloud solutions, and data validation. Established in 1969 and headquartered in Stone, United Kingdom, Instem primarily generates revenue from its study management segment, with a significant market presence in the United States and additional operations in Europe and other regions. By driving productivity and efficiency, Instem supports life sciences organizations in their pursuit of safer and more effective products.

Philip Reason

CEO and Board Member

8 past transactions

d-Wise

Acquisition in 2021
d-Wise is a provider of life science solutions and technology consulting services based in Morrisville, North Carolina. The company focuses on modernizing clinical trial analysis environments and offers strategic consulting and technology services to enhance data management and analysis. Their expertise includes validating open-source tools, anonymizing data and documents, and facilitating transitions to the public cloud. d-Wise is dedicated to improving business results for its customers while contributing to a healthier world through innovative solutions in the life sciences sector.

The Edge Software Consultancy

Acquisition in 2021
Their mission is to improve the productivity of scientists The pharmaceutical industry is facing a difficult challenge, how to improve the efficiency and productivity of research and development without stifling innovation. The Edge offers a unique combination of scientific knowledge and IT innovation. This allows their consultants to communicate effectively with a wide range of scientific disciplines, translating their needs into requirements that empower IT teams to deliver more effective solutions.

Leadscope

Acquisition in 2019
LeadScope, Inc. specializes in the development and marketing of a chemoinformatics application that provides access to critical research data. The company offers a range of services including toxicity databases, data management, decision support solutions, and tools for in silico toxicology, data mining, high-throughput screening analysis, lead optimization, and compound acquisition. LeadScope serves a diverse clientele that includes national laboratories, pharmaceutical and biotechnology firms, chemical manufacturers, consumer products companies, and regulatory agencies across the United States, Canada, and Europe. Founded in 1997 and headquartered in Columbus, Ohio, LeadScope operates as a subsidiary of Instem plc as of November 2019.

Notocord

Acquisition in 2016
Notocord is a software publisher that specializes in data acquisition, analysis, and reporting for experimental drug research. The company's solutions are tailored for various fields, including cardiovascular, respiratory, and electrophysiology signal analysis, and are primarily utilized in Safety Pharmacology, Toxicology, research and development, as well as academic and preclinical studies. Notocord's flagship product, Notocord-hem Evolution, is a versatile software platform that integrates advanced modules to offer customized configurations for users. Recognized as a leader in its field, Notocord's products are employed by many of the top pharmaceutical research companies globally, reflecting its significant presence in the competitive landscape of drug development research software.

Samarind

Acquisition in 2016
Samarind provides Regulatory Information Management (RIM) solutions to the life sciences sector that significantly improve the quality of regulatory information and help achieve and maintain compliance for pharmaceutical, biotech and medical device products. Samarind is well known in the marketplace for its commitment to the ongoing development of high quality, sophisticated, user-friendly and well-architected software solutions. Samarind solutions are in use by customers around the world and are supported by a level of customer service that is setting a new benchmark for client satisfaction within the life sciences. The Samarind RMS solution suite of software and services gives clients the ability to manage the entire medicinal product life cycle without having to enter information twice. Samarind RMS provides the security, flexibility and ease of use that regulatory affairs teams need to achieve and exceed their regulatory and commercial goals. Samarind RMS is a robust user-friendly software application that precisely manages the key areas of product license acquisition and maintenance, including eCTD, EVMPD, IDMP, Drug Safety and Medical Devices.

Logos Technologies

Acquisition in 2013
Logos Technologies, Inc. serves customers across a broad range of technologies and services, including biofuels research, advanced nuclear engineering, national security services including cyber defense, and system design and integration including persistent surveillance systems for aircraft and aerostats. Logos continuously is developing advanced capabilities in advanced methods of energy production

BioWisdom

Acquisition in 2011
BioWisdom delivers intelligence for the Healthcare Industry and helps clients to navigate the complex scientific and commercial issues involved in developing successful healthcare products. The company provides a powerful suite of software tools for the acquisition, integration, visualization and high value analysis of healthcare intelligence. The BioWisdom team combines extensive experience of the pharmaceutical and biotechnology industries with proven expertise in life science software development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.